DC-ATA AV-OVA-1
1 abstract
Abstract
Randomized phase 2 trial of personal dendritic cell (DC)-autologous tumor antigen (ATA) vaccines in newly diagnosed advanced ovary cancer.Org: University of Colorado Cancer Center, Hoag Gynecologic Oncology, Scripps Clinic/Green Hospital, University of California San Diego, Moores Cancer Center, University of California Irvine,